Skip to content
OpenCapital
Get started

Emergent Biosolutions EBS EPS (Diluted)

EPS (Diluted) at other companies

Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
$4.43+11.3%
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
$6.75-7.2%
AMP
Amphastar PharmaceuticalsAMPH
$0.14-72.5%
Amneal Pharmaceuticals, Inc. logo
Amneal Pharmaceuticals, Inc.AMRX
$0.19+375%
Collegium Pharmaceutical, Inc. logo
Collegium Pharmaceutical, Inc.COLL
$0.40+471%
Opko Health logo
Opko HealthOPK
-$0.07+30.0%

Other financials

Income statement

See full
Revenue$156.1M-29.7%
Gross profit$84.1M-37.1%
Operating income$10.5M-79.0%
Net income$6.8M-90.0%

Balance sheet

See full
Cash & equivalents$161.5M+5.7%
Total debt$584.6M-13.1%
Total equity$523.1M-5.4%
Total assets$1.3B-7.4%

Cash flow

See full
Operating cash flow-$33.8M-202%
CapEx$2.4M-33.3%
Free cash flow-$36.2M-145%

Valuation

See full
Market cap$411.74M+22.0%
Enterprise value$834.84M-2.6%
P/E3.6×—
P/S0.6×+0.3×

Profitability

See full
Gross margin54.2%+19.0pp
Operating margin15%+10.3pp
Net margin9.6%+5.8pp
FCF margin20.8%—

Returns & leverage

See full
Return on equity13.9%+8.1pp
Debt / equity1.1×-0.1×
Current ratio4.3×-2.0×

Where this comes from

Reported directly by Emergent Biosolutions in its filing.

Tagged under the XBRL concept us-gaap:EarningsPerShareDiluted.

The official record: Emergent Biosolutions’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Emergent Biosolutions's eps (diluted).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Emergent Biosolutions's EPS (diluted)?
Emergent Biosolutions (EBS) reported EPS (diluted) of $0.07 in Q1 2026.
How has Emergent Biosolutions's EPS (diluted) changed year-over-year?
Emergent Biosolutions's EPS (diluted) decreased by 94.1% year-over-year, from $1.19 to $0.07.
What is the long-term trend for Emergent Biosolutions's EPS (diluted)?
Over 3 years (2021 to 2024), Emergent Biosolutions's EPS (diluted) has grown at a -3.0% compound annual growth rate (CAGR), from $4.07 to -$3.72.
What does EPS (diluted) mean?
Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.